JP2010526840A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526840A5
JP2010526840A5 JP2010507811A JP2010507811A JP2010526840A5 JP 2010526840 A5 JP2010526840 A5 JP 2010526840A5 JP 2010507811 A JP2010507811 A JP 2010507811A JP 2010507811 A JP2010507811 A JP 2010507811A JP 2010526840 A5 JP2010526840 A5 JP 2010526840A5
Authority
JP
Japan
Prior art keywords
proportions
mixtures
compound according
treatment
pharmaceutically usable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010507811A
Other languages
English (en)
Japanese (ja)
Other versions
JP5543335B2 (ja
JP2010526840A (ja
Filing date
Publication date
Priority claimed from DE102007022565A external-priority patent/DE102007022565A1/de
Application filed filed Critical
Publication of JP2010526840A publication Critical patent/JP2010526840A/ja
Publication of JP2010526840A5 publication Critical patent/JP2010526840A5/ja
Application granted granted Critical
Publication of JP5543335B2 publication Critical patent/JP5543335B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010507811A 2007-05-14 2008-04-18 複素環式インダゾール誘導体 Expired - Fee Related JP5543335B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007022565A DE102007022565A1 (de) 2007-05-14 2007-05-14 Heterocyclische Indazolderivate
DE102007022565.4 2007-05-14
PCT/EP2008/003143 WO2008138448A2 (de) 2007-05-14 2008-04-18 Heterocyclische indazolderivate

Publications (3)

Publication Number Publication Date
JP2010526840A JP2010526840A (ja) 2010-08-05
JP2010526840A5 true JP2010526840A5 (enExample) 2011-06-02
JP5543335B2 JP5543335B2 (ja) 2014-07-09

Family

ID=39837777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507811A Expired - Fee Related JP5543335B2 (ja) 2007-05-14 2008-04-18 複素環式インダゾール誘導体

Country Status (10)

Country Link
US (1) US8334309B2 (enExample)
EP (1) EP2155728B1 (enExample)
JP (1) JP5543335B2 (enExample)
AR (1) AR066557A1 (enExample)
AU (1) AU2008250706B2 (enExample)
CA (1) CA2687162C (enExample)
DE (1) DE102007022565A1 (enExample)
ES (1) ES2548444T3 (enExample)
IL (1) IL202034A (enExample)
WO (1) WO2008138448A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
US8791112B2 (en) 2011-03-30 2014-07-29 Arrien Pharmaceuticals Llc Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
WO2012173099A1 (ja) * 2011-06-14 2012-12-20 塩野義製薬株式会社 血管内皮リパーゼ阻害活性を有するアミノ誘導体
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR20160104612A (ko) 2013-07-26 2016-09-05 업데이트 파마 인코포레이트 비산트렌의 치료 효과 개선용 조성물
WO2016138335A1 (en) * 2015-02-27 2016-09-01 Lycera Corporation Indazolyl thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease
WO2018039539A1 (en) * 2016-08-26 2018-03-01 Lycera Corporation Indazolyl-l,2,4-thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease
GB201801226D0 (en) * 2018-01-25 2018-03-14 Redx Pharma Plc Modulators of Rho-associated protein kinase
US20220289692A1 (en) * 2019-09-06 2022-09-15 Inflazome Limited Nlrp3 inhibitors
CN111548320B (zh) * 2019-10-09 2023-03-24 贵州大学 一类1，3，4-噁二唑酰肼类化合物及其制备方法和应用
GB202200735D0 (en) * 2022-01-20 2022-03-09 Redx Pharma Plc Compounds

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227841A (en) 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DE19917990A1 (de) 1999-04-20 2000-11-02 Florian Lang Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk
US6897231B2 (en) 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
DE10042137A1 (de) 2000-08-28 2002-03-14 Florian Lang sgk2 und sgk3 als diagnostische und therapeutische Targets
US7115617B2 (en) * 2001-08-22 2006-10-03 Amgen Inc. Amino-substituted pyrimidinyl derivatives and methods of use
WO2003051847A1 (en) 2001-12-19 2003-06-26 Smithkline Beecham P.L.C. (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
FR2836915B1 (fr) * 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2411655T3 (es) 2002-05-17 2013-07-08 Pfizer Italia S.R.L. Derivados de aminoindazol activos como inhibidores de quinasas, procedimiento para su preparación y composiciones farmacéuticas que los comprenden
EP1537087B1 (fr) 2002-09-05 2012-11-28 Aventis Pharma S.A. Derives de 3-aminoindazole comme inhibiteurs de kinase et compositions pharmaceutiques les renfermant
FR2844267B1 (fr) 2002-09-05 2008-02-15 Aventis Pharma Sa Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
AU2003293376A1 (en) 2002-12-10 2004-06-30 Imclone Systems Incorporated Anti-angiogenic compounds and their use in cancer treatment
FR2848554A1 (fr) 2002-12-12 2004-06-18 Aventis Pharma Sa Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant
WO2004062662A1 (fr) 2002-12-12 2004-07-29 Aventis Pharma S.A. Derives d'aminoindazoles et leur utilisation comme inhibiteurs de kinases
US20050019366A1 (en) 2002-12-31 2005-01-27 Zeldis Jerome B. Drug-coated stents and methods of use therefor
WO2005000813A1 (en) 2003-05-30 2005-01-06 Imclone Systems Incorporated Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors
US20050090529A1 (en) 2003-07-31 2005-04-28 Pfizer Inc 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
CN102060806A (zh) 2003-09-11 2011-05-18 iTherX药品公司 细胞因子抑制剂
JP4110324B2 (ja) 2003-10-15 2008-07-02 宇部興産株式会社 新規インダゾール誘導体
US20060004043A1 (en) 2003-11-19 2006-01-05 Bhagwat Shripad S Indazole compounds and methods of use thereof
US20050107386A1 (en) 2003-11-19 2005-05-19 Rama Krishna Narla Methods of treating diseases and disorders by targeting multiple kinases
AR046787A1 (es) 2003-12-05 2005-12-21 Bristol Myers Squibb Co Agentes antimigrana heterociclicos
DE102004028862A1 (de) * 2004-06-15 2005-12-29 Merck Patent Gmbh 3-Aminoindazole
MX2007004551A (es) 2004-10-18 2007-05-23 Amgen Inc Compuestos tiadiazol y metodos de uso.
WO2006105865A1 (de) * 2005-04-04 2006-10-12 Merck Patent Gmbh Indazol-quadratsäurederivate als chk1-, chk2- und sgk- inhibitoren
DE102007002717A1 (de) * 2007-01-18 2008-07-24 Merck Patent Gmbh Heterocyclische Indazolderivate

Similar Documents

Publication Publication Date Title
JP2010526840A5 (enExample)
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
WO2007107470A3 (en) Pyrazoles as 11-beta-hsd-1
WO2007060140A3 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
JP2004519469A5 (enExample)
JP2016512825A5 (enExample)
JP2012533546A5 (enExample)
JP2006504795A5 (enExample)
IL187005A0 (en) Diacylglycerol acyltransferase inhibitors
RU2012123372A (ru) Гетероциклические модуляторы транспортеров атф-связывающей кассеты
WO2020113213A3 (en) Cyclic pantetheine derivatives and uses thereof
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
EA201000702A1 (ru) Некоторые производные 2-пиразинона и их применение в качестве ингибиторов нейтрофильной эластазы
JP2010520246A5 (enExample)
TW200643013A (en) Pyrazoles
JP2017222722A5 (enExample)
JP2017522300A5 (enExample)
CN115605485A (zh) 大环化合物的固体形式及其制备和用途
JP2009517411A5 (enExample)
JP2009518415A5 (enExample)
CA2596145A1 (en) Prevention and treatment of thromboembolic disorders
JP2016530238A5 (enExample)
JP2016515550A5 (enExample)
CN115803328A (zh) 哌嗪-2,3-二酮衍生物及其在医药上的应用